The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and 10 other professional societies have issued new appropriate use criteria (AUC) for lymphoscintigraphy in sentinel node mapping and ...

Lymphatic mapping, a recent technique first developed for the management of melanoma, is based on the concept that information about the status of the entire lymphatic drainage from a tumor site could ...

Sentinel node mapping in gastric cancer surgery is an intraoperative strategy designed to identify the first-echelon lymph nodes that directly drain a gastric tumour. By using tracer substances and ...

A systematic review and meta-analysis demonstrates that human papillomavirus positivity in cervical cancer is associated with better overall, cancer-specific, and disease-free survival. HPV Types in ...

Trends of Utilization of Systemic Therapies for Metastatic Renal Cell Carcinoma in the Canadian Health Care System Lymph node involvement is one of the most important factors influencing recurrence ...

The lymph node ratio as prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision and postoperative chemoradiotherapy *Minimum follow up of 12 months for both ...

Trials evaluating the omission of completion axillary-lymph-node dissection in patients with clinically node-negative breast cancer and sentinel-lymph-node metastases have been compromised by limited ...

Through the use of preoperative axillary ultrasound (AUS), more patients with clinical node‑positive (cNI) breast cancer and ...

A test that combines clinicopathologic factors and a tumor’s gene expression profile (CP-GEP) reliably identified patients with a less than 10% risk for a positive sentinel lymph node biopsy — though ...

US regulators have approved a new radioactive diagnostic imaging agent manufactured by Navidea Biopharmaceuticals that is intended to assist in the location of lymph nodes in patients with breast ...

Melanoma is the third most common cancer in Australia, and there are as many victims in their 20s and 30s as later in life. While prospects for those with advanced melanoma are grim compared with many ...